Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes Read More » October 2, 2025
CSL Vifor and Travere Therapeutics Support Updated KDIGO IgA Nephropathy Guidelines Read More » September 26, 2025
FDA Reviews Shionogi’s COVID-19 Prevention Pill NDA as the First Oral Therapy Read More » September 2, 2025
